Share on LinkedInShare on LinkedIn

ARTICLE · 01 NOVEMBER 2013

Are Patented Medicines Too Expensive?

The TAC (Treatment Action Campaign) has again this week lashed out at South African patent law saying that patented medicines are too expensive.

South AfricaIntellectual Property
Bredenkamp Attorneys
Bredenkamp Attorneys

Patent law, expensive (?) medicine and the TAC

The TAC (Treatment Action Campaign) has again this week lashed out at South African patent law saying that patented medicines are too expensive.

On the one hand, these medicines would not have existed were it not for patent laws.  Innovation has to be stimulated by the promise of reward.

On the other hand, one has to ask how big that reward should be.  You could argue that the bigger the reward, the more money is available for research and development to create even better medicines.  Surely this makes business sense? But some say the drug companies are just enriching themselves.

There is however the moral dilemma that some patients cannot afford lifesaving drugs.  Again, these drugs would not have existed were it not for patent laws, but now they do.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from